|
Our goals are
as follows:
|
Short-Term Goal |
|
Release non-prescription products
to the market, addressing the needs in skin care
field for adjunct therapy. The products should
be able to be dispensed at physicianˇ¦s practices
or professionalˇ¦s offices for consumers to
obtain and use, under the guidance of the
physicians or professionals. |
| ˇ@ |
|
Mid-Term Goal |
|
Establish
topical drug delivery system for dermatological
products, which can be used to formulate both
for non-prescription and for prescription-only
preparations. The main characteristic is
targeted drug delivery into skin. The active
compounds should be delivered at the right skin
site (layer, depth, type) through the intended
pathway (transcellular or follicular ) and at
the right dose for the designated duration. |
| ˇ@ |
|
Long-Term Goal |
|
Active
pharmaceutical ingredients in the appropriate
dosage forms and delivery systems for
dermatological indications. The final products
are effective, safe and convenient to use. The
effectiveness and safety are achieved on the
basis of more efficient delivery into skin and
reduction of unused materials on the surface. |
GENEPHARM has assembled 4 technology platforms:
|
Calcium-T |
|
|
Aero-Foli |
|
|
Gel-Pad |
|
|
Anti-psoriatic drug |
GENEPHARM has
set up two Research & Development centers:
Innovation R&D Center in Sunnyvale, California, USA
Application R&D Center in Nankang, Taipei, Taiwan
ˇ@ |
